Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,636 | 595 | 99.0% |
| Education | $91.00 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $933.93 | 71 | $0 (2024) |
| Novo Nordisk Inc | $907.40 | 60 | $0 (2024) |
| ABBVIE INC. | $841.09 | 60 | $0 (2024) |
| PFIZER INC. | $838.29 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $787.55 | 29 | $0 (2024) |
| Amgen Inc. | $656.83 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $420.42 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $385.33 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $261.16 | 23 | $0 (2023) |
| Allergan, Inc. | $224.79 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,449 | 85 | PFIZER INC. ($334.93) |
| 2023 | $1,603 | 115 | AbbVie Inc. ($258.94) |
| 2022 | $1,426 | 91 | Amgen Inc. ($303.97) |
| 2021 | $1,064 | 70 | Amgen Inc. ($146.95) |
| 2020 | $688.36 | 47 | Allergan, Inc. ($132.93) |
| 2019 | $948.18 | 68 | AstraZeneca Pharmaceuticals LP ($180.08) |
| 2018 | $704.28 | 51 | AstraZeneca Pharmaceuticals LP ($117.05) |
| 2017 | $844.20 | 71 | Lilly USA, LLC ($113.34) |
All Payment Transactions
598 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: UROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: PAIN | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Obesity | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: PAIN | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: PAIN | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: PAIN | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: VACCINES | ||||||
| 08/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 2,799 | 3,766 | $288,353 | $117,516 |
| 2022 | 43 | 2,672 | 3,476 | $246,826 | $108,411 |
| 2021 | 36 | 2,410 | 3,192 | $233,180 | $98,170 |
| 2020 | 32 | 2,142 | 2,959 | $204,849 | $79,827 |
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 177 | 191 | $48,323 | $19,731 | 40.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 157 | 157 | $25,944 | $18,524 | 71.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 231 | $47,124 | $17,846 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 153 | $20,196 | $8,397 | 41.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 82 | 84 | $6,132 | $5,929 | 96.7% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 35 | 35 | $5,250 | $4,719 | 89.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 173 | 189 | $11,718 | $3,111 | 26.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 156 | 156 | $5,148 | $2,649 | 51.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 163 | 313 | $4,382 | $2,610 | 59.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 88 | 90 | $3,780 | $2,574 | 68.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 149 | 149 | $4,917 | $2,530 | 51.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $4,752 | $2,415 | 50.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 174 | 224 | $9,856 | $2,318 | 23.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 172 | 177 | $7,788 | $2,309 | 29.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,564 | $1,999 | 78.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 172 | 243 | $9,477 | $1,849 | 19.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $2,448 | $1,842 | 75.2% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 48 | 48 | $2,112 | $1,792 | 84.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 48 | 48 | $13,200 | $1,665 | 12.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 43 | 46 | $4,554 | $1,334 | 29.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 67 | 141 | $6,204 | $1,290 | 20.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 35 | 35 | $1,400 | $1,258 | 89.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 27 | $4,950 | $1,144 | 23.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 19 | 45 | $2,745 | $729.90 | 26.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 13 | 14 | $1,386 | $703.92 | 50.8% |
About Dr. Bethany Duff, MD
Dr. Bethany Duff, MD is a Family Medicine healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2011. The National Provider Identifier (NPI) number assigned to this provider is 1750675724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bethany Duff, MD has received a total of $8,727 in payments from pharmaceutical and medical device companies, with $1,449 received in 2024. These payments were reported across 598 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,636).
As a Medicare-enrolled provider, Duff has provided services to 10,023 Medicare beneficiaries, totaling 13,393 services with total Medicare billing of $403,924. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Manhattan, KS
- Active Since 06/07/2011
- Last Updated 09/11/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750675724
Products in Payments
- VRAYLAR (Drug) $513.22
- NURTEC ODT (Drug) $383.77
- TRULICITY (Drug) $369.41
- JARDIANCE (Drug) $357.15
- BREZTRI (Drug) $273.06
- TEZSPIRE (Biological) $265.73
- Ozempic (Drug) $264.77
- FARXIGA (Drug) $247.04
- Wegovy (Drug) $232.83
- MOUNJARO (Drug) $222.52
- UBRELVY (Drug) $213.04
- TRELEGY ELLIPTA (Drug) $189.44
- XIFAXAN (Drug) $174.18
- Saxenda (Drug) $166.55
- Rybelsus (Drug) $160.41
- Vascepa (Drug) $146.05
- PREVNAR 20 (Biological) $145.40
- ELIQUIS (Drug) $141.11
- EVENITY (Biological) $140.61
- Otezla (Drug) $134.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Manhattan
Bradley Harrison, M.d, M.D
Family Medicine — Payments: $451,744
Dr. Kent Kiracofe, M.d, M.D
Family Medicine — Payments: $186,788
Dr. Kyle Platz, D.o, D.O
Family Medicine — Payments: $52,764
Dr. Cary Herl, Md, MD
Family Medicine — Payments: $8,424
Dr. Jacqi Lambert, M.d, M.D
Family Medicine — Payments: $8,316
Dr. Debra Doubek, M.d, M.D
Family Medicine — Payments: $6,497